Browse by Condition in Portland
And 38 more conditions with trials in Portland
Recruiting Clinical Trials in Portland
NCT03511118 · Duke University
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
NCT06218914 · Phase 1 · AstraZeneca
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
NCT06731478 · Phase 3 · Daiichi Sankyo
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
NCT05703971 · Phase 1/2 · Genprex, Inc.
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
NCT07095894 · Phase 3 · Jaeb Center for Health Research
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
NCT07733765 · Phase 3 · Pfizer
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
NCT04682483 · Tufts Medical Center
Cardiogenic Shock Working Group Registry
NCT07094087 · Phase 3 · CSL Behring
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
NCT04380740 · Phase 2 · Boston Children's Hospital
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
NCT06953089 · Phase 2 · DualityBio Inc.
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
NCT07205718 · Phase 1/2 · Takeda
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
NCT07725796 · Phase 1 · UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
Top Study Sponsors in Portland
| Sponsor | Recruiting studies |
|---|---|
| Oregon Health and Science University | 76 |
| OHSU Knight Cancer Institute | 36 |
| VA Office of Research and Development | 14 |
| AstraZeneca | 7 |
| Bristol-Myers Squibb | 6 |
| National Cancer Institute (NCI) | 5 |
| University of Washington | 5 |
| AbbVie | 4 |
Trials in Portland by Phase
| Phase | Studies |
|---|---|
| Early Phase 1 | 3 |
| Phase 1 | 45 |
| Phase 1/2 | 45 |
| Phase 2 | 54 |
| Phase 2/3 | 4 |
| Phase 3 | 32 |
| Phase 4 | 20 |
| Not phased | 167 |
46 of these studies accept healthy volunteers.
Clinical Trials in Portland: Common Questions
How many clinical trials are recruiting in Portland, OR?
370 clinical trials list a recruiting site in Portland, OR, across 68 conditions on HelloStudys. Counts update daily from ClinicalTrials.gov.
What conditions are being studied in Portland?
The most active research areas in Portland right now are rheumatoid arthritis, leukemia, essential tremor. Browse by condition above to see each study.
Who sponsors clinical trials in Portland?
The sponsors with the most recruiting studies in Portland include Oregon Health and Science University, OHSU Knight Cancer Institute, VA Office of Research and Development.
Are there clinical trials for healthy volunteers in Portland?
Yes. 46 of the recruiting studies in Portland accept healthy volunteers.
Does it cost anything to join a clinical trial?
Study-related visits, tests and treatment are typically provided at no cost to participants, and some studies reimburse travel or time. Each study sets its own terms, so confirm with the study team before enrolling.
About Clinical Trials in Portland, OR
Portland, OR is home to 370 actively recruiting clinical trials across 68 medical conditions as of 2026. The most active research areas include rheumatoid arthritis, leukemia, essential tremor. Clinical trials offer free access to new treatments and expert medical care. Participation is always voluntary, and you can withdraw at any time.